Net sales 63,500 hundred million yen, operating income 3,200 million yen, ordinary income 3,360 million yen, net income attributable to owners of parent 2,250 million yen, year-over-year +21.6%, +62.0%, +53.0%, +49.3% respectively. Highest first-half results on record. Strong demand for AI and data centers and expansion of medical business supported multiple segments. Interim dividend of 50 yen, including a 10 yen 100th anniversary commemorative dividend. Expect one-time costs in the second half related to acquisition of two companies’ shares, but full-year forecast upgraded.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7510","jir_company_name":"Takebishi Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7510-20261030-03.pdf","jir_short_summary":"Net sales 63,500 hundred million yen, operating income 3,200 million yen, ordinary income 3,360 million yen, net income attributable to owners of parent 2,250 million yen, year-over-year +21.6%, +62.0%, +53.0%, +49.3% respectively. Highest first-half results on record. Strong demand for AI and data centers and expansion of medical business supported multiple segments. Interim dividend of 50 yen, including a 10 yen 100th anniversary commemorative dividend. Expect one-time costs in the second half related to acquisition of two companies' shares, but full-year forecast upgraded.","jir_summary":"### Overview of Performance\nFor the second quarter of the fiscal year ending March 2027, net sales were 63,500 hundred million yen, operating income was 3,200 million yen, ordinary income was 3,360 million yen, and net income attributable to owners of parent (interim) was 2,250 million yen, achieving significant year-over-year revenue and profit growth. Capturing demand from AI and data centers and growth in the medical business boosted multiple segments, resulting in the highest first-half performance on record.\n\n### Outlook and Capital Return\nAn interim dividend of 50 yen was paid, including a 10 yen 100th anniversary commemorative dividend. While one-time expenses related to acquisition of shares in two companies are expected in the second half, the full-year earnings forecast has been revised upward. Under the mid-term plan \"T-Link1369,\" the company aims for further growth by capturing AI and semiconductor demand and promoting M&A.","jir_financial_highlights":"Net Sales: 63,500 hundred million yen (+21.6%)\nOperating Income: 3,200 million yen (+62.0%)\nOrdinary Income: 3,360 million yen (+53.0%)\nNet Income Attributable to Owners of Parent (Interim): 2,250 million yen (+49.3%)","jir_category":"","jir_hashtags":"#NoMentionOfShareBuybackOrPartnerships1, #NoSpecificIRTheme2","jir_key_figures":"Net Sales: 63,500 hundred million yen\nOperating Income: 3,200 million yen\nOrdinary Income: 3,360 million yen","jir_meta_title":"Takebishi Corporation Supplementary Explanation Materials | FY2027 Q2 (Interim)","jir_meta_description":"Summary of Takebishi Corporation's supplementary explanation materials: first-half net sales 63,500 hundred million yen, operating income 3,200 million yen, ordinary income 3,360 million yen, interim net income 2,250 million yen; key points include expansion of AI and data center demand, growth in the medical business, dividend policy and revision of full-year forecasts.","jir_og_title":"Takebishi Corporation Supplementary Financial Explanation | FY2027 Q2 (Interim)","jir_og_description":"Takebishi Corporation's Q2 results: net sales 63,500 hundred million yen, operating income 3,200 million yen, ordinary income 3,360 million yen, interim net income 2,250 million yen. Explains AI demand, medical business growth, dividend policy and revised full-year forecast.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"\u201926\/3\\\",\\\"\u201927\/3\\\"],\\\"datasets\\\":[{\\\"data\\\":[522,635],\\\"label\\\":\\\"Net Sales\\\"}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"\u201926\/3\\\",\\\"\u201927\/3\\\"],\\\"datasets\\\":[{\\\"data\\\":[33.6,32.0],\\\"label\\\":\\\"Operating Income\\\"}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Industrial Equipment\\\",\\\"Systems\\\",\\\"Semiconductors & Devices\\\",\\\"Social & ICT\\\",\\\"Electronic Medical\\\"],\\\"datasets\\\":[{\\\"data\\\":[192,233,145,174,233]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"\u201926\/3\\\",\\\"\u201927\/3\\\"],\\\"datasets\\\":[{\\\"data\\\":[0.0,0.0],\\\"label\\\":\\\"ROE\\\"}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Full-Year Guidance Comparison\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Before Revision\\\",\\\"After Revision\\\"],\\\"datasets\\\":[{\\\"data\\\":[47,55],\\\"label\\\":\\\"Ordinary Income\\\"}]}\"}]","ir_related_company":57027,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-139013","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n